ALERT: The M&A Class Action Firm Continues Investigating the Merger – VKIN, GRNA, FRG, AAIC
07 juin 2023 16h54 HE
|
Monteverde & Associates PC
NEW YORK, June 07, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
Moore Kuehn Encourages REUN, AAIC, DM, and WTT Investors to Contact Law Firm
02 juin 2023 10h48 HE
|
Moore Kuehn
NEW YORK, June 02, 2023 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
ALERT: The M&A Class Action Firm Continues Investigating the Merger – FRG, GRNA, EMBK, AAIC
31 mai 2023 16h51 HE
|
Monteverde & Associates PC
NEW YORK, May 31, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
AB Science annonce que les résultats de son étude de phase 3 dans la maladie d’Alzheimer ont été présentés à la AAIC
29 juil. 2021 12h07 HE
|
AB Science
COMMUNIQUE DE PRESSE LES RESULTATS DE L’ETUDE DU MASITINIB AB09004 DANS LES FORMES LEGERES A MODEREES DE LA MALADIE D’ALZHEIMER ONT ETE PRESENTES A LA ALZHEIMER’S ASSOCIATION INTERNATIONAL...
AB Science announced that results from its Phase 3 AB09004 study on mild to moderate Alzheimer’s disease have been presented at the AAIC
29 juil. 2021 12h07 HE
|
AB Science
PRESS RELEASE RESULTS FROM MASITINIB STUDY AB09004 IN MILD TO MODERATE ALZHEIMER’S DISEASE PRESENTED AT THE ANNUAL ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE (AAIC) WITH THE FULL ABSTRACT...
AB Science annonce qu’un résumé de son étude de phase 3 dans la maladie d’Alzheimer a été sélectionné pour une présentation orale à la Alzheimer’s Association International Conference (AAIC)
22 juil. 2021 12h10 HE
|
AB Science
COMMUNIQUE DE PRESSE AB SCIENCE PRESENTERA LES RESULTATS DE SON ETUDE DE PHASE 3 AB09004 DANS LES FORMES LEGERES A MODEREES DE LA MALADIE D’ALZHEIMER LORS DE LA PLUS GRANDE CONFERENCE MONDIALE SUR LA...
AB Science today announced that an abstract reporting results from its Phase 3 AB09004 study on Alzheimer’s disease has been selected for an oral presentation at the annual Alzheimer’s Association International Conference (AAIC)
22 juil. 2021 12h10 HE
|
AB Science
PRESS RELEASE AB SCIENCE TO PRESENT RESULTS FROM ITS PHASE III AB09004 STUDY IN MILD TO MODERATE ALZHEIMER’S DISEASE AT THE WORLD'S LARGEST CONFERENCE FOR ALZHEIMER’S AND DEMENTIA RESEARCH (AAIC...
Biogen to Host Investor Webcast to Discuss Alzheimer’s Disease Portfolio on July 25, 2018
20 juil. 2018 08h39 HE
|
Biogen Inc.
CAMBRIDGE, Mass., July 20, 2018 (GLOBE NEWSWIRE) -- Biogen (Nasdaq:BIIB) today announced it will host a live webcast providing a Q&A session related to its Alzheimer’s disease investigational...
Axsome Therapeutics Announces AXS-05 Presentation at the 2018 Alzheimer’s Association International Conference
17 juil. 2018 07h00 HE
|
Axsome Therapeutics, Inc.
NEW YORK, July 17, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ:AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous...
DiamiR Announces Oral Presentation at 2016 Alzheimer's Association International Conference
21 juil. 2016 08h30 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ --(Marketwired - July 21, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today that the...